Pacira Pharmaceuticals buy Piper Sandler
Start price
03.07.24
/
50%
€20.40
Target price
03.07.25
€38.93
Performance (%)
-5.39%
End price
04.07.25
€19.30
Summary
This prediction ended on 04.07.25 with a price of €19.30. With a performance of -5.39%, the BUY prediction for Pacira Pharmaceuticals by Piper_Sandler closed slightly in the red. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | 4.737% | 4.737% | -7.870% |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Piper_Sandler for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $42.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten